| For: | Yu SJ, Kim YJ. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. World J Gastroenterol 2014; 20(34): 12039-12044 [PMID: 25232241 DOI: 10.3748/wjg.v20.i34.12039] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12039.htm |
| Number | Citing Articles |
| 1 |
Tsung-Hsing Hung, Chih-Chun Tsai, Hsing-Feng Lee. Population-based study of Entecavir and long-term mortality in chronic hepatitis B–related decompensated liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2019; 43(6) doi: 10.1016/j.clinre.2019.02.010
|
| 2 |
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Hyeseung Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma. Gut and Liver 2016; 10(6) doi: 10.5009/gnl15527
|
| 3 |
Ying Shi, Haipeng Zhang, Zhu Han, Xuguang Mi, Wenyan Zhang, Mingyu Lv. HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner. Tumor Biology 2016; 37(3) doi: 10.1007/s13277-015-4076-9
|
| 4 |
Julián Piñeiro Fernández, Kimberly A. Luddy, Cathal Harmon, Cliona O’Farrelly. Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function. International Journal of Molecular Sciences 2019; 20(17) doi: 10.3390/ijms20174131
|
| 5 |
Wei-Shan Chin, Shin-Chun Pan, Ching-Chun Huang, Pei-Jer Chen, Yue Leon Guo. Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma. Liver Cancer 2022; 11(5) doi: 10.1159/000525346
|
| 6 |
Pengfei Zhang, Yu Yang, Feng Wen, John Wheeler, Ping Fu, Qiu Li. Cost‐effectiveness analysis of antiviral therapy in patients with advanced hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib. Journal of Gastroenterology and Hepatology 2016; 31(12) doi: 10.1111/jgh.13425
|
| 7 |
Yung‐Tsung Li, Hui‐Lin Wu, Jia‐Horng Kao, Huei‐Ru Cheng, Ming‐Chih Ho, Chih‐Chiang Wang, Pei‐Jer Chen, Ding‐Shinn Chen, Chun‐Jen Liu. Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma. Hepatology 2019; 70(1) doi: 10.1002/hep.30581
|
| 8 |
Dali Zhang, Danni Feng, Minjuan Ren, Ying Bai, Zhenwen Liu, Hongbo Wang. Preoperative serum hepatitis B virus DNA was a risk factor for hepatocellular carcinoma recurrence after liver transplantation. Annals of Medicine 2022; 54(1) doi: 10.1080/07853890.2022.2107233
|
| 9 |
Camila V Pereira, Cristiane Valle Tovo, Thiago K Grossmann, Henrique Mirenda, Bruna B Dal-Pupo, Paulo RL de Almeida, Angelo A de Mattos. Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil. Memórias do Instituto Oswaldo Cruz 2016; 111(4) doi: 10.1590/0074-02760150390
|
| 10 |
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Jia-Hui Lin, Wen-Shu Chen, Woei-Cherng Shyu, Han-Chieh Wu, Cheng-Yuan Peng, Ih-Jen Su, Long-Bin Jeng. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence. Viruses 2020; 12(8) doi: 10.3390/v12080796
|
| 11 |
Hussain Al-Turaifi. Evaluation of nucleic acid testing for blood donors: One year study. International Journal of Blood Transfusion and Immunohematology 2015; 5(2) doi: 10.5348/ijbti-2015-18-OA-4
|
| 12 |
Carolina Silva, Diogo Ramos, Miriam Quina, Elizabeth Pádua. Hepatitis B Virus Genotypes and Subgenotypes Circulating in Infected Residents in a Country with High Vaccination Rate. Viruses 2024; 16(6) doi: 10.3390/v16060954
|
| 13 |
Xiaole Fan, Hongxin Yuan, Suming Zhao, Xiaohu Yang, Rongfeng Shi, Jingli Wang, Hui Zhao. Epigenetic age acceleration of early stage hepatocellular carcinoma tightly associated with hepatitis B virus load, immunoactivation, and improved survival. Cancer Biology & Therapy 2020; 21(10) doi: 10.1080/15384047.2020.1804284
|
| 14 |
Marie Atsama Amougou, Agnes Marchio, Berthold Bivigou‐Mboumba, Dominique Noah Noah, Robert Banai, Paul Jean Adrien Atangana, Paul Fewou Moundipa, Pascal Pineau, Richard Njouom. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon. Journal of Viral Hepatitis 2019; 26(9) doi: 10.1111/jvh.13131
|
| 15 |
Yutaka Handa, Ethan Yichen Lee, Yasuhito Tanaka. Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan. Hepatology Research 2026; doi: 10.1111/hepr.70179
|
| 16 |
Hanxin Feng, Chunbo Yang, Feng Xu, Yang Zhao, Tianqiang Jin, Zeyuan Wei, Dexin Wang, Chaoliu Dai. Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: A propensity score matching analysis. European Journal of Surgical Oncology 2022; 48(2) doi: 10.1016/j.ejso.2021.08.035
|
| 17 |
Xiaofan Lu, Jialin Meng, Haitao Wang, Yujie Zhou, Jianguo Zhou, Xinjia Ruan, Yi Chen, Yuqing Ye, Liwen Su, Xiaole Fan, Hangyu Yan, Liyun Jiang, Fangrong Yan. DNA replication stress stratifies prognosis and enables exploitable therapeutic vulnerabilities of HBV-associated hepatocellular carcinoma: An <i>in-silico</i> precision oncology strategy. The Innovation Medicine 2023; 1(1) doi: 10.59717/j.xinn-med.2023.100014
|
| 18 |
Hongxia Cui, Su Li, Wu Lv, Jing Xiang. Association of hepatitis B virus DNA levels with efficacy and safety and the impact of antiviral therapy on prognosis in liver cancer patients receiving immune checkpoint inhibitors therapy: a systematic review and meta-analysis. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1501139
|
| 19 |
Nicholas Noverati, Rukaiya Bashir-Hamidu, Dina Halegoua-DeMarzio, Hie-Won Hann. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress. International Journal of Molecular Sciences 2022; 23(7) doi: 10.3390/ijms23073917
|
| 20 |
Shaowei Xu, Qingqing Pang, Meng Wei, Danxi Liu, Du Yuan, Tao Bai, Xiaobo Wang, Zhihong Tang, Feixiang Wu. Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1598193
|
| 21 |
Sri Harsha Kombathula, Jeewan Ram Vishnoi, Puneet Pareek, Rakesh Kumar Vyas. A comment on the Sun et al trial 'Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: An open-label randomized controlled trial'. Radiotherapy and Oncology 2020; 147 doi: 10.1016/j.radonc.2020.03.042
|
| 22 |
Xiao-Jun Lin, Xiang-Ming Lao, Ming Shi, Sheng-Ping Li. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment. Digestive Diseases and Sciences 2016; 61(9) doi: 10.1007/s10620-016-4167-5
|
| 23 |
Sen Lu, Yuan-yuan Gao, Wen-yu Shao, Guo-yong Han, Wen-zhou Ding, Xin-li Huang. Complete mitochondrial genome sequence and mutations of the liver cancer model inbred C57BL/6 mice strain. Mitochondrial DNA Part A 2016; 27(3) doi: 10.3109/19401736.2014.974160
|
| 24 |
Satoru Hagiwara, Naoshi Nishida, Ah-Mee Park, Yoriaki Komeda, Toshiharu Sakurai, Tomohiro Watanabe, Masatoshi Kudo. Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10570-0
|
| 25 |
Wenhong Zhang, Dazhi Zhang, Xiaoguang Dou, Qing Xie, Jiaji Jiang, Xinyue Chen, Hong Ren. Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology 2018; 6(1) doi: 10.14218/JCTH.2017.00073
|
| 26 |
Yi Chen, Mengjia Huang, Junkai Zhu, Li Xu, Wenxuan Cheng, Xiaofan Lu, Fangrong Yan. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.857060
|
| 27 |
Vivian N. Nwude, Olufunmilayo A. Lesi, Charles Onyekwere, Emilie Charpentier, Judith M. Hübschen. Clinical Characteristics of Hepatitis B Virus-Associated Hepatocellular Carcinoma Patients in Southwest Nigeria. Pathogens 2025; 14(2) doi: 10.3390/pathogens14020169
|
| 28 |
Irfan Sana. Experience with Hepatitis B Viral load Testing in Jharkhand. Archives of Hepatitis Research 2019; doi: 10.17352/ahr.000021
|
| 29 |
Bashiru Garba, Amino Adan Mohamud, Fartuun Hassan Mohamed, Ayan Aden Moussa, Yusuf Yakubu, Najib Isse Dirie, Aya Muktar Abdulatif, Jamal Hassan Mohamoud, Abdirasak Sharif Ali, Abdurrahman Hassan Jibril, Ashraf Elbahrawy. Prevalence, risk factors, and viral load quantification of HBV infection among hospital patients: A cross-sectional investigation in Mogadishu, Somalia. PLOS One 2026; 21(1) doi: 10.1371/journal.pone.0340800
|
| 30 |
Shuncong Wang, Haiqing Ma, Xuemin Li, Xiangqiong Mo, Haiyu Zhang, Lewei Yang, Yun Deng, Yan Yan, Guangwei Yang, Xingwei Liu, Huanhuan Sun. DNASE1L3 as an indicator of favorable survival in hepatocellular carcinoma patients following resection. Aging 2020; 12(2) doi: 10.18632/aging.102675
|
| 31 |
Vahdat Poortahmasebi, Seyed Moayed Alavian, Azam Ghaziasadi, Arezou Azadi, Mohsen Nasiri Toosi, Seyed Mohammad Jazayeri. Detection and Quantification of Hepatitis B Virus Genomes in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B Virus Infection, Cirrhosis, and Hepatocellular Carcinoma Patients. Hepatitis Monthly 2022; 21(10) doi: 10.5812/hepatmon.120982
|
| 32 |
Rui Liao, Cheng-You Du, Jian-Ping Gong, Fang Luo. HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection. Journal of Oncology 2018; 2018 doi: 10.1155/2018/9289421
|
| 33 |
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
|
| 34 |
V. A. Zinserling, E. V. Esaulenko, V. E. Karev, A. B. Bubochkin, A. A. Sukhoruk, E. O. Shibaeva, M. V. Ponyatishina. Clinical and morphological correlations in occult hepatitis B. Arkhiv patologii 2017; 79(6) doi: 10.17116/patol20177968-13
|
| 35 |
Hao Zhang, Jia-Hang Du, Zhi-Yong Lu, De-Di Wu, Lin Ma, Jian-Yong Yang, Yong-Hui Huang, Ying−Qiang Zhang. HBV reactivation in HCC patients following TACE: risk factors, antiviral therapy impact, and survival analysis. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1818955
|
| 36 |
Andrew Meillier, Shyam Patel, Abdullah M. S. Al-Osaimi. Readability of Healthcare Literature for Hepatitis B and C. Digestive Diseases and Sciences 2015; 60(12) doi: 10.1007/s10620-015-3808-4
|
| 37 |
Shenghua Hao, Ping Fan, Shaofei Chen, Caixue Tu, Chidan Wan. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2017; 21(2) doi: 10.1007/s11605-016-3311-z
|
| 38 |
Yaqin Zhang, Weihua Cao, Shiyu Wang, Lu Zhang, Xinxin Li, Ziyu Zhang, Yao Xie, Minghui Li. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence 2024; 15(1) doi: 10.1080/21505594.2024.2421231
|
| 39 |
Xiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, Yan-Yan Yu, Jia Shang, Zu-Jiang Yu, Qing Mao, Qing Xie, Wei Zhao, Jun Li, Zhi-Liang Gao, Shan-Ming Wu, Hong Tang, Jun Cheng, Xin-Yue Chen, Wen-Hong Zhang, Hao Wang, Zhong-Nan Xu, Ling Wang, Jun Dai, Jing-Hang Xu. Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks. World Journal of Clinical Cases 2021; 9(18): 4690-4699 doi: 10.12998/wjcc.v9.i18.4690
|
| 40 |
Jiaming Shen, Xia Wang, Ningning Wang, Shifei Wen, Guangde Yang, Li Li, Juanjuan Fu, Xiucheng Pan. HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1179689
|
| 41 |
Jiaming Shen, Xia Wang, Guangde Yang, Li Li, Juanjuan Fu, Wei Xu, Qingqiao Zhang, Xiucheng Pan. Liver Injury and Its Impact on Prognosis in Patients with HBV-Related Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors Plus Immune Checkpoint Inhibitors. Journal of Hepatocellular Carcinoma 2024; doi: 10.2147/JHC.S431191
|
| 42 |
Yiqi Xiong, Ziling Wang, Jiajun Liu, Kang Li, Yonghong Zhang. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model. Microorganisms 2024; 12(5) doi: 10.3390/microorganisms12050976
|
| 43 |
Cuiyun Wu, Yaosheng Luo, Yinghui Chen, Hongling Qu, Lin Zheng, Jie Yao. Development of a prognostic gene signature for hepatocellular carcinoma. Cancer Treatment and Research Communications 2022; 31 doi: 10.1016/j.ctarc.2022.100511
|
| 44 |
Daniela Păcurar, Alexandru Dinulescu, Gheorghiță Jugulete, Alexandru-Sorin Păsărică, Irina Dijmărescu. Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania. Life 2024; 14(3) doi: 10.3390/life14030348
|
| 45 |
Ximing Li, Zijie Wu, Zhijun He, Yanchao Xu, Wenbin Xie, Shitong Huang, Lingxiao Chen, Zheng Gao, Siqi Tang, Xiangdong Gao, Hong Tian. The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies. Journal of Gastroenterology and Hepatology 2026; 41(5) doi: 10.1111/jgh.70309
|
| 46 |
Jin Shang, Shanling Xu, Jiaxing Zhang, Xuting Ran, Lang Bai, Hong Tang. Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis. Oncotarget 2017; 8(65) doi: 10.18632/oncotarget.21299
|
| 47 |
Chia‐Jui Yen, Yu‐Lin Ai, Hung‐Wen Tsai, Shih‐Huang Chan, Chia‐Sheng Yen, Kuang‐Hsiung Cheng, Yun‐Ping Lee, Chia‐Wei Kao, Yu‐Chun Wang, Yi‐Lin Chen, Cheng‐Han Lin, Tsunglin Liu, Huey‐Pin Tsai, Jen‐Ren Wang, Ih‐Jen Su, Wenya Huang. Hepatitis B virus surface gene pre‐S2 mutant as a high‐risk serum marker for hepatoma recurrence after curative hepatic resection. Hepatology 2018; 68(3) doi: 10.1002/hep.29790
|
| 48 |
Kuan‐I Lee, Po‐Cheng Liang, Po‐Yau Hsu, Tyng‐Yuan Jang, Yu‐Ju Wei, Ching‐I Huang, Ming‐Yen Hsieh, Zu‐Yau Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu. Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences 2023; 39(11) doi: 10.1002/kjm2.12744
|
| 49 |
Qian Gao, Xuejiao Li, Li Wang, Xiaozhi Tan, Zhe Li, Chengfang Xu. The effect of intrahepatic cholestasis in pregnancy combined with different stages of hepatitis B virus infection on pregnancy outcomes: a retrospective study. BMC Pregnancy and Childbirth 2024; 24(1) doi: 10.1186/s12884-024-06460-9
|
| 50 |
Haohan Liu, Yongcong Yan, Jianhong Lin, Chuanchao He, Hao Liao, Huoming Li, Zhenyu Zhou, Jie Wang, Kai Mao, Zhiyu Xiao. Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis. Molecular Therapy - Nucleic Acids 2022; 29 doi: 10.1016/j.omtn.2022.08.008
|
| 51 |
Yun Wang, Xiaogang Xiang, Liwen Chen, Zhujun Cao, Rebecca Bao, Huijuan Zhou, Weiliang Tang, Jie Lu, Lanyi Lin, Qing Xie, Shisan Bao, Hui Wang. Randomized clinical trial: Nucleos(t)ide analogues improved survival of CHB-related HCC patientsviareducing severity and progression of malignancy. Oncotarget 2016; 7(36) doi: 10.18632/oncotarget.10155
|
| 52 |
Philippe Pérot, Jacques Fourgeaud, Claire Rouzaud, Béatrice Regnault, Nicolas Da Rocha, Hélène Fontaine, Jérôme Le Pavec, Samuel Dolidon, Margaux Garzaro, Delphine Chrétien, Guillaume Morcrette, Thierry Jo Molina, Agnès Ferroni, Marianne Leruez-Ville, Olivier Lortholary, Anne Jamet, Marc Eloit. Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France. Emerging Infectious Diseases 2023; 29(2) doi: 10.3201/eid2902.221468
|
| 53 |
Chiao-Fang Teng, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses 2020; 12(9) doi: 10.3390/v12090945
|
| 54 |
Shousheng Liu, Jinfa Lai, Ning Lyu, Qiankun Xie, Huijiao Cao, Dabiao Chen, Meng He, Bei Zhang, Ming Zhao. Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.582504
|
| 55 |
Gangfeng Zhu, Qiang Yi, Rui Xu, Yi Xie, Siying Chen, Yipeng Song, Yi Xiang, Xiangcai Wang, Li Huang. Development and validation of a machine learning model for predicting pulmonary metastasis in hepatocellular carcinoma patients. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03353-x
|
| 56 |
Peng Li, Wei Huang, Feng Wang, Ye-Fang Ke, Lin Gao, Ke-Qing Shi, Meng-Tao Zhou, Bi-Cheng Chen. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I/II hepatocellular carcinoma. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20180464
|
| 57 |
Shay Behrens, Xin Wei Wang. Dissecting intratumor heterogeneity in HCC: new research strategies and clinical implications. Carcinogenesis 2022; 43(12) doi: 10.1093/carcin/bgac099
|